Randall C Schatzman's Net Worth
$9.18 Million
Who is Randall C Schatzman?
Randall C Schatzman has an estimated net worth of $9.18 Million. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, and Bolt Biotherapeutics, Inc..
SEC CIK
Randall C Schatzman's CIK is 0001604763
Past Insider Trading and Trends
2016 was Randall C Schatzman's most active year for acquiring shares with 16 total transactions. Randall C Schatzman's most active month to acquire stocks was the month of January. 2016 was Randall C Schatzman's most active year for disposing of shares, totalling 32 transactions. Randall C Schatzman's most active month to dispose stocks was the month of April. 2017 saw Randall C Schatzman paying a total of $49,500.00 for 305,000 shares, this is the most they've acquired in one year. In 2015 Randall C Schatzman cashed out on 240,000 shares for a total of $5,499,981.51, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALDER BIOPHARMACEUTICALS INC No price found
President and CEORandall C Schatzman owns 115,172 units of Common Stock and 114,784 units of Commom Stock. In the year 2014 Randall C Schatzman filed a total of 20 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
$13.34 | -$701,256.00 | 115.17K |
Scheduled
|
Feb 9
| ||
Form 4
| +0.35% | 404 |
$20.20 | $8,160.80 | 115.17K |
Nov 30 - Jan 27
| |||
Form 4
|
—
|
0
|
$13.41 | -$235,105.00 | 114.77K |
Scheduled
|
Nov 7
| ||
Form 4
|
—
|
0
|
$16.21 | -$244,461.69 | 114.77K |
Scheduled
|
Oct 3
| ||
Form 4
|
—
|
0
|
$16.88 | -$312,170.00 | 114.77K |
Scheduled
|
Sep 1
| ||
Form 4
|
—
|
0
|
$16.47 | -$298,863.35 | 349.15K |
Scheduled
|
Aug 1
| ||
Form 4
|
—
|
0
|
$14.68 | -$268,155.00 | 114.77K |
Scheduled
|
Jul 25
| ||
Form 4
|
—
|
0
|
$15.46 | -$283,893.84 | 114.77K |
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
$14.65 | -$267,524.81 | 112.95K |
Scheduled
|
May 20 - May 24
| ||
Form 4
|
—
|
0
|
$14.38 | -$821,616.65 | 112.95K |
Scheduled
|
Apr 14 - Apr 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
$15.93 | -$310,897.00 | 111.58K |
Scheduled
|
Jan 4
| ||
Form 4
|
—
|
0
|
$18.82 | -$368,581.00 | 111.58K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$17.05 | -$333,216.40 | 109.92K |
Scheduled
|
Nov 2
| ||
Form 4
|
—
|
0
|
$19.68 | -$1,928,835.00 | 109.92K |
May 26
| |||
Form 4
| -47.64% | -100.00K |
$28.42 | -$2,842,399.12 | 109.92K |
Scheduled
|
Jan 26 - Jan 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bolt Biotherapeutics, Inc. (BOLT) Snapshot price: $0.641
Chief Executive OfficerRandall C Schatzman owns 12,859 units of Common Stock which is worth $8,242.62. From 2021 to 2024 Randall C Schatzman acquired a total of 6,500 shares in Bolt Biotherapeutics, Inc. at a cost of $34,908.75.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 5
| +63.62% | 5K |
$0.98 | $4,908.75 | 12.86K |
Jun 6 - Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
∞
| 1.5K |
$20.00 | $30,000.00 | 1.5K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||